Estradiol Completed Phase N/A Trials for Postmenopausal Period / Postmenopausal Osteoporosis (PMO)

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01064453Angeliq Regulatory Post Marketing Surveillance